Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

Enrolling by invitation · Phase 1

Conditions studied: Non-Tuberculous Mycobacterial (NTM) Pneumonia, Mycobacterium Abscessus Infection

In brief

This study aims to use mycobacteriophage therapy, using identified in-vitro effective Mycobacteriophage Muddy\_HRMN0052, along with combination conventional antimycobacterial therapy for their NTM pulmonary disease with Mycobacterium abscessus with goal to reduce infection burden and improve pulmonary disease

Key facts

Study ID

NCT07228702

Run by

Vancouver Coastal Health

People needed

1

Starts

2026-01-11

Expected to finish

2027-10-01

Last updated by the study team

2026-06-03

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• consent to participation

You may not qualify if…

• non-consent to participation

Where it is running

• Vancouver General Hospital Non-Tuberculous Mycobacterial Disease Clinic — Vancouver, British Columbia, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.